Found: 44
Select item for more details and to access through your institution.
The effects of dendritic cell-based vaccines in the tumor microenvironment: Impact on myeloid-derived suppressor cells.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1050484
- By:
- Publication type:
- Article
Persistence of SARS-CoV-2 Infection in Severely Immunocompromised Patients With Complete Remission B-Cell Lymphoma and Anti-CD20 Monoclonal Antibody Therapy: A Case Report of Two Cases.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.860891
- By:
- Publication type:
- Article
Low Levels of Granulocytic Myeloid-Derived Suppressor Cells May Be a Good Marker of Survival in the Follow-Up of Patients With Severe COVID-19.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2021.801410
- By:
- Publication type:
- Article
MULTI-CRITERIA DECISION ANALYSIS AS A DECISION-SUPPORT TOOL FOR DRUG EVALUATION: A PILOT STUDY IN A PHARMACY AND THERAPEUTICS COMMITTEE SETTING.
- Published in:
- International Journal of Technology Assessment in Health Care, 2018, v. 34, n. 5, p. 519, doi. 10.1017/S0266462318000569
- By:
- Publication type:
- Article
MULTI-CRITERIA DECISION ANALYSIS AS A DECISION-SUPPORT TOOL FOR DRUG EVALUATION: A PILOT STUDY IN A PHARMACY AND THERAPEUTICS COMMITTEE SETTING.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A genetic profiling guideline to support diagnosis and clinical management of lymphomas.
- Published in:
- Clinical & Translational Oncology, 2024, v. 26, n. 5, p. 1043, doi. 10.1007/s12094-023-03307-1
- By:
- Publication type:
- Article
Cancer Nano-Immunotherapy: The Novel and Promising Weapon to Fight Cancer.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 2, p. 1195, doi. 10.3390/ijms25021195
- By:
- Publication type:
- Article
Matrix Metalloproteinase-9 Expression Is Associated with the Absence of Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Patients.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 14, p. 11297, doi. 10.3390/ijms241411297
- By:
- Publication type:
- Article
Defining the Emergence of New Immunotherapy Approaches in Breast Cancer: Role of Myeloid-Derived Suppressor Cells.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 6, p. 5208, doi. 10.3390/ijms24065208
- By:
- Publication type:
- Article
Obesity and Risk for Lymphoma: Possible Role of Leptin.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 24, p. 15530, doi. 10.3390/ijms232415530
- By:
- Publication type:
- Article
Impact of obesity-associated myeloid-derived suppressor cells on cancer risk and progression (Review).
- Published in:
- International Journal of Oncology, 2024, v. 65, n. 2, p. N.PAG, doi. 10.3892/ijo.2024.5667
- By:
- Publication type:
- Article
Quality of life with palbociclib plus fulvestrant versus placebo plus fulvestrant in postmenopausal women with endocrine-sensitive hormone receptor-positive and HER2-negative advanced breast cancer: patient-reported outcomes from the FLIPPER trial.
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359221148921
- By:
- Publication type:
- Article
Single-cell protein secretomic signatures as potential correlates to tumor cell lineage evolution and cell-cell interaction.
- Published in:
- Frontiers in Oncology, 2013, v. 3, p. 1, doi. 10.3389/fonc.2013.00010
- By:
- Publication type:
- Article
Recent Therapeutic Advances and Change in Treatment Paradigm of Patients with Merkel Cell Carcinoma.
- Published in:
- Oncologist, 2019, v. 24, n. 10, p. 1375, doi. 10.1634/theoncologist.2018-0718
- By:
- Publication type:
- Article
Cancer and Immune Response: Old and New Evidence for Future Challenges.
- Published in:
- Oncologist, 2008, v. 13, n. 12, p. 1246, doi. 10.1634/theoncologist.2008-0166
- By:
- Publication type:
- Article
Nivolumab plus ipilimumab in metastatic melanoma: a critical appraisal focused on specific subpopulations.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1187840
- By:
- Publication type:
- Article
Radiation for awakening the dormant immune system, a promising challenge to be explored.
- Published in:
- Frontiers in Immunology, 2014, v. 5, p. 1, doi. 10.3389/fimmu.2014.00102
- By:
- Publication type:
- Article
coBRIM: a phase 3, double-blind, placebo-controlled study of vemurafenib versus vemurafenib + cobimetinib in previously untreated BRAF<sup>V600</sup> mutation-positive patients with unresectable locally advanced or metastatic melanoma (NCT01689519).
- Published in:
- 2015
- By:
- Publication type:
- Abstract
Development and validation of a sexual relations satisfaction scale in patients with breast cancer - "SEXSAT-Q".
- Published in:
- 2019
- By:
- Publication type:
- journal article
Leptin, Both Bad and Good Actor in Cancer.
- Published in:
- Biomolecules (2218-273X), 2021, v. 11, n. 6, p. 913, doi. 10.3390/biom11060913
- By:
- Publication type:
- Article
Publisher Correction: Circulating immune biomarkers in peripheral blood correlate with clinical outcomes in advanced breast cancer.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Circulating immune biomarkers in peripheral blood correlate with clinical outcomes in advanced breast cancer.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-93838-w
- By:
- Publication type:
- Article
Role of consolidation with yttrium-90 ibritumomab tiuxetan in patients with advanced-stage follicular lymphoma.
- Published in:
- Therapeutic Advances in Hematology, 2014, v. 5, n. 3, p. 78, doi. 10.1177/2040620714532282
- By:
- Publication type:
- Article
Tumor Microenvironment and Immune Effects of Antineoplastic Therapy in Lymphoproliferative Syndromes.
- Published in:
- Journal of Biomedicine & Biotechnology, 2010, p. 1, doi. 10.1155/2010/846872
- By:
- Publication type:
- Article
New insights into the role of the immune microenvironment in breast carcinoma.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Role of Immune Escape Mechanisms in Hodgkin's Lymphoma Development and Progression: A Whole New World with Therapeutic Implications.
- Published in:
- Clinical & Developmental Immunology, 2012, p. 1, doi. 10.1155/2012/756353
- By:
- Publication type:
- Article
Immune Microenvironment in Colorectal Cancer: A New Hallmark to Change Old Paradigms.
- Published in:
- Clinical & Developmental Immunology, 2011, p. 1, doi. 10.1155/2011/174149
- By:
- Publication type:
- Article
Immunometabolism Modulation in Therapy.
- Published in:
- Biomedicines, 2021, v. 9, n. 7, p. 798, doi. 10.3390/biomedicines9070798
- By:
- Publication type:
- Article
Dendritic cells: the yin and yang in disease progression.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2023.1321051
- By:
- Publication type:
- Article
Circulating myeloid-derived suppressor cells may be a useful biomarker in the follow-up of unvaccinated COVID-19 patients after hospitalization.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1266659
- By:
- Publication type:
- Article
Sarcoidosis-like reaction induced by immune checkpoint inhibitor in a patient with hepatocellular carcinoma: a case report.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1150128
- By:
- Publication type:
- Article
Prognostic Implications of the Residual Tumor Microenvironment after Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Patients without Pathological Complete Response.
- Published in:
- Cancers, 2023, v. 15, n. 3, p. 597, doi. 10.3390/cancers15030597
- By:
- Publication type:
- Article
Ewing Sarcoma Meets Epigenetics, Immunology and Nanomedicine: Moving Forward into Novel Therapeutic Strategies.
- Published in:
- Cancers, 2022, v. 14, n. 21, p. 5473, doi. 10.3390/cancers14215473
- By:
- Publication type:
- Article
BERENICE Final Analysis: Cardiac Safety Study of Neoadjuvant Pertuzumab, Trastuzumab, and Chemotherapy Followed by Adjuvant Pertuzumab and Trastuzumab in HER2-Positive Early Breast Cancer.
- Published in:
- Cancers, 2022, v. 14, n. 11, p. 2596, doi. 10.3390/cancers14112596
- By:
- Publication type:
- Article
Tumor Immune Microenvironment in Lymphoma: Focus on Epigenetics.
- Published in:
- Cancers, 2022, v. 14, n. 6, p. 1469, doi. 10.3390/cancers14061469
- By:
- Publication type:
- Article
Role of Isolated Limb Perfusion in the Era of Targeted Therapies and Immunotherapy in Melanoma. A Systematic Review of The Literature.
- Published in:
- Cancers, 2021, v. 13, n. 21, p. 5485, doi. 10.3390/cancers13215485
- By:
- Publication type:
- Article
Pembrolizumab Plus Gemcitabine in the Subset of Triple-Negative Advanced Breast Cancer Patients in the GEICAM/2015-04 (PANGEA-Breast) Study.
- Published in:
- Cancers, 2021, v. 13, n. 21, p. 5432, doi. 10.3390/cancers13215432
- By:
- Publication type:
- Article
Lower Survival and Increased Circulating Suppressor Cells in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma with Deficit of Vitamin D Levels Using R-GDP Plus Lenalidomide (R2-GDP): Results from the R2-GDP-GOTEL Trial.
- Published in:
- Cancers, 2021, v. 13, n. 18, p. 4622, doi. 10.3390/cancers13184622
- By:
- Publication type:
- Article
Integrating the Tumor Microenvironment into Cancer Therapy.
- Published in:
- Cancers, 2020, v. 12, n. 6, p. 1677, doi. 10.3390/cancers12061677
- By:
- Publication type:
- Article
Unraveling transformation of follicular lymphoma to diffuse large B-cell lymphoma.
- Published in:
- PLoS ONE, 2019, v. 14, n. 2, p. 1, doi. 10.1371/journal.pone.0212813
- By:
- Publication type:
- Article
Transformed follicular lymphoma in the rituximab era: A report from the Spanish Lymphoma Oncology Group.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Metabolic Classification and Intervention Opportunities for Tumor Energy Dysfunction.
- Published in:
- Metabolites (2218-1989), 2021, v. 11, n. 5, p. 264, doi. 10.3390/metabo11050264
- By:
- Publication type:
- Article
Health-related quality of life impact of cobimetinib in combination with vemurafenib in patients with advanced or metastatic BRAF<sup>V600</sup> mutation-positive melanoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Clinical features of serous retinopathy observed with cobimetinib in patients with BRAF-mutated melanoma treated in the randomized coBRIM study.
- Published in:
- 2017
- By:
- Publication type:
- journal article